Firm to seek 1st approval for stem cell-based medicine The Japan News Cells in such fluid will be cultured and used for treating graft versus host disease (GVHD), a side effect of bone marrow or umbilical cord blood transplant surgery. The body of a person with GVHD is attacked by immune cells in transplanted bone marrow ... |
